A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006)

Clinical trial NCT07709000 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07709000
Sponsor: Merck Sharp & Dohme LLC
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukaemia Small Lymphocytic Lymphoma Hematologic Malignancies

Start date: 2026-08-21
Primary completion: 2033-11-16
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.